Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas
Authors
Keywords
Cancer treatment, Lymphoma cells, Lymphomas, B cells, Gene expression, Chromatin, Cyclophosphamide, Drug therapy
Journal
PLoS One
Volume 9, Issue 12, Pages e111840
Publisher
Public Library of Science (PLoS)
Online
2014-12-11
DOI
10.1371/journal.pone.0111840
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
- (2014) S. K. Knutson et al. MOLECULAR CANCER THERAPEUTICS
- An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1
- (2013) Kyle D. Konze et al. ACS Chemical Biology
- EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation
- (2013) Wendy Béguelin et al. CANCER CELL
- Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma
- (2013) Bjoern Chapuy et al. CANCER CELL
- Identification of EZH2 and EZH1 Small Molecule Inhibitors with Selective Impact on Diffuse Large B Cell Lymphoma Cell Growth
- (2013) Shivani Garapaty-Rao et al. CHEMISTRY & BIOLOGY
- Drugging the human methylome: an emerging modality for reversible control of aberrant gene transcription
- (2013) Tim J Wigle et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Non-Hodgkin’s B-cell lymphoma: Advances in molecular strategies targeting drug resistance
- (2013) Steve A Maxwell et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
- (2013) Robert H. Oakley et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Target identification and mechanism of action in chemical biology and drug discovery
- (2013) Monica Schenone et al. Nature Chemical Biology
- Emerging roles for chromatin as a signal integration and storage platform
- (2013) Aimee I. Badeaux et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
- (2013) S. K. Knutson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- Targeting genetic alterations in protein methyltransferases for personalized cancer therapeutics
- (2012) R A Copeland et al. ONCOGENE
- Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
- (2012) W. Qi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
- (2012) J. G. Lohr et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Dynamical-Systems View of Stem Cell Biology
- (2012) C. Furusawa et al. SCIENCE
- Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
- (2011) Scott R. Daigle et al. CANCER CELL
- Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells
- (2011) George Schlossmacher et al. JOURNAL OF ENDOCRINOLOGY
- Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
- (2011) Ryan D. Morin et al. NATURE
- Crosstalk between TNF and glucocorticoid receptor signaling pathways
- (2010) Tom Van Bogaert et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Current treatment strategy of diffuse large B-cell lymphomas
- (2010) Nozomi Niitsu INTERNATIONAL JOURNAL OF HEMATOLOGY
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
- (2010) Ryan D Morin et al. NATURE GENETICS
- Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk
- (2009) P. J. Barrett-Lee et al. ANNALS OF ONCOLOGY
- A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy
- (2009) W. W.L. Choi et al. CLINICAL CANCER RESEARCH
- Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action
- (2009) Emira Ayroldi et al. FASEB JOURNAL
- Protein methyltransferases as a target class for drug discovery
- (2009) Robert A. Copeland et al. NATURE REVIEWS DRUG DISCOVERY
- p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
- (2008) Andrei V. Budanov et al. CELL
- Dynamic access of the glucocorticoid receptor to response elements in chromatin
- (2008) Anuja A. George et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Interaction of the Glucocorticoid Receptor with the Chromatin Landscape
- (2008) Sam John et al. MOLECULAR CELL
- Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
- (2008) G. Lenz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started